Antony E. Pfaffle, M.D.

Antony Pfaffle, M.D. has served as Chief Scientific Officer at CorMedix since January 1, 2013, and was a Director of CorMedix from 2007-2016. He was an Advisory Medical Director for ParagonRx, an Inventiv Company specializing in drug and device risk evaluation and mitigation. Dr. Pfaffle had been Director of Healthcare Research at Bearing Circle Capital, L.P., an investment fund, from May 2007 to July 2010. He was a Managing Director at Paramount BioCapital, Inc. and Senior Vice President of Business Development at Paramount BioSciences, LLC from December 2005 to May 2007. Dr. Pfaffle was a Principal and Founder of Black Diamond Research, an investment research company, from July 2001 to December 2005. Dr. Pfaffle is an internist who practiced nephrology at New York Hospital-Weill Cornell Medical Center, Lenox Hill Hospital and Memorial Sloan-Kettering Cancer Center. Dr. Pfaffle received his M.D. from New York Medical College.